Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
247
-
Total 13F shares, excl. options
-
3,155,408
-
Shares change
-
-249,376
-
Total reported value, excl. options
-
$509,245,856
-
Value change
-
-$41,077,763
-
Put/Call ratio
-
0%
-
Number of buys
-
70
-
Number of sells
-
131
-
Price
-
$161.33
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2025
As of 30 Jun 2025 FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 281 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,155,408 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, LPL Financial LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, UBS Group AG, Royal Bank of Canada, RAYMOND JAMES FINANCIAL INC, ENVESTNET ASSET MANAGEMENT INC, Berger Financial Group, Inc, and GOLDMAN SACHS GROUP INC.
This table shows 281 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.